Scout | PAR-25-133: NINDS SBIR (U44) funding for exploratory neuroscience clinical trials via NeuroNEXT

This opportunity is no longer accepting applications.

grant PAR-25-133

NINDS SBIR (U44) funding for exploratory neuroscience clinical trials via NeuroNEXT

Summary

NINDS invites SBIR Phase II (U44) applications from small businesses to conduct exploratory clinical trials or biomarker studies for non-stroke neurological disorders using the NeuroNEXT network. Applicants must use NeuroNEXT’s standardized infrastructure (CCC/DCC, master agreements, central IRB), and projects with independent third‑party investment receive priority. Phase 1b/2a multi-center a…

To facilitate the cooperation and partnering of public and private funding organizations, universities, academic medical centers, research institutes, contract research organizations, biotechnology companies, and pharmaceutical companies, NINDS formed the Network for Excellence in Neuroscience C…

Funding Source

Agency: National Institutes of Health

Sub-agency: National Institute of Neurological Disorders and Stroke

Awards & funding

Award Ceiling: $3M

Eligibility

SBCs majority-owned and controlled (>50%) by U.S. citizens or permanent resident aliens (or by other concerns that are each majority-owned/controlled by such individuals)

SBCs owned by an Indian Tribe, Alaska Native Corporation (ANC), or Native Hawaiian Organization (NHO), or a wholly‑owned business entity of such tribe/ANC/NHO

SBCs majority-owned by multiple venture capital operating companies, hedge funds, or private equity firms (SBIR-only), provided no single such firm owns >50% unless that firm itself qualifies as a small business majority-owned and controlled by U.S. individuals

Eligible Joint Ventures of SBCs – each venturer must independently meet SBIR ownership criteria in 3(i) or 3(ii); JVs including any 3(ii) venturer must comply with 13 CFR 121.705(b)

Only U.S. Small Business Concerns (SBCs) are eligible to apply to this NOFO (SBIR Phase II). Key SBIR eligibility criteria for the applicant organization at time of award:

Organized for profit; has a place of business located in the United States; operates primarily in the U.S. or m…

Dates

Application Window Closes: September 5, 2027

Opportunity Released: November 12, 2024

Open for Submission: November 12, 2024

Submission Deadline: September 5, 2027

Supporting links

National Institutes of Health

Secure Grant Funding 10x Faster

Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.

Get a Demo Sign Up

Already have an account? Sign In

Trusted by 500+ Happy Customers